Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery EpCam

Path Created with Sketch.
Go to EpCam Normal Tissue GalleryGo back to Product Page
Adrenal gland - Adrenocortical adenoma displaying a weak membranous EPCAM positivity.
Adrenal gland – Adrenocortical adenoma displaying a weak membranous EPCAM positivity.
Adrenal gland - EPCAM negative adrenocortical adenoma.
Adrenal gland – EPCAM negative adrenocortical adenoma.
Adrenal gland - EPCAM negative pheochromocytoma .
Adrenal gland – EPCAM negative pheochromocytoma .
Breast - Invasive breast cancer of no special type (NST) with strong EPCAM immunostaining of tumor cells.
Breast – Invasive breast cancer of no special type (NST) with strong EPCAM immunostaining of tumor cells.
Breast - Invasive lobular breast cancer with moderate EPCAM immunostaining of tumor cells.
Breast – Invasive lobular breast cancer with moderate EPCAM immunostaining of tumor cells.
Colon - Colorectal adenocarcinoma with strong EPCAM immunostaining of tumor cells.
Colon – Colorectal adenocarcinoma with strong EPCAM immunostaining of tumor cells.
Esophagus - Adenocarcinoma with strong EPCAM immunostaining of tumor cells.
Esophagus – Adenocarcinoma with strong EPCAM immunostaining of tumor cells.
Esophagus - Squamous cell carcinoma with focal, weak to moderate EPCAM immunostaining of tumor cells.
Esophagus – Squamous cell carcinoma with focal, weak to moderate EPCAM immunostaining of tumor cells.
Kidney - Chromophobe renal cell carcinoma with strong membranous EPCAM immunostaining of tumor cells.
Kidney – Chromophobe renal cell carcinoma with strong membranous EPCAM immunostaining of tumor cells.
Kidney - Clear cell renal cell carcinoma with weak to moderate membranous EPCAM immunostaining of tumor cells.
Kidney – Clear cell renal cell carcinoma with weak to moderate membranous EPCAM immunostaining of tumor cells.
Kidney - Papillary renal cell carcinoma with strong basolateral membranous EPCAM immunostaining of tumor cells.
Kidney – Papillary renal cell carcinoma with strong basolateral membranous EPCAM immunostaining of tumor cells.
Liver - Cholangiocellular carcinoma with strong EPCAM immunostaining of tumor cells.
Liver – Cholangiocellular carcinoma with strong EPCAM immunostaining of tumor cells.
Liver - EPCAM negative hepatocellular carcinoma.
Liver – EPCAM negative hepatocellular carcinoma.
Liver - Hepatocellular carcinoma with moderate membranous EPCAM immunostaining.
Liver – Hepatocellular carcinoma with moderate membranous EPCAM immunostaining.
Lung - Adenocarcinoma with strong EPCAM immunostaining of tumor cells.
Lung – Adenocarcinoma with strong EPCAM immunostaining of tumor cells.
Lung - Small cell carcinoma with strong EPCAM immunostaining of tumor cells.
Lung – Small cell carcinoma with strong EPCAM immunostaining of tumor cells.
Lymph node - Diffuse large B-cell lymphoma with moderate to strong EPCAM immunostaining of tumor cells.
Lymph node – Diffuse large B-cell lymphoma with moderate to strong EPCAM immunostaining of tumor cells.
Ovary - Malignant mixed Mullerian tumor with strong EPCAM immunostaining of epitheloid tumor cells while spindle-shaped tumor cells are negative.
Ovary – Malignant mixed Mullerian tumor with strong EPCAM immunostaining of epitheloid tumor cells while spindle-shaped tumor cells are negative.
Ovary - Serous high-grade carcinoma with strong EPCAM immunostaining of tumor cells.
Ovary – Serous high-grade carcinoma with strong EPCAM immunostaining of tumor cells.
Pancreas - Neuroendocrine tumor with strong diffuse EPCAM positivity of tumor cells.
Pancreas – Neuroendocrine tumor with strong diffuse EPCAM positivity of tumor cells.
Penis - EPCAM negative squamous cell carcinoma.
Penis – EPCAM negative squamous cell carcinoma.
Penis - Squamous cell carcinoma with prominent focal membranous EPCAM immunostaining of tumor cells.
Penis – Squamous cell carcinoma with prominent focal membranous EPCAM immunostaining of tumor cells.
Prostate - Adenocarcinoma (Gleason 3+3=6) with strong EPCAM immunostaining of tumor cells.
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong EPCAM immunostaining of tumor cells.
Skin - Basal cell carcinoma showing strong EpCAM staining of tumor cells.
Skin – Basal cell carcinoma showing strong EpCAM staining of tumor cells.
Skin - Basal cell carcinoma with intense EpCAM positivity of all tumor cells.
Skin – Basal cell carcinoma with intense EpCAM positivity of all tumor cells.
Skin - Squamous cell carcinoma lacking EpCAM staining.
Skin – Squamous cell carcinoma lacking EpCAM staining.
Skin - Basal cell carcinoma with intense EpCAM positivity of all tumor cells.
Skin – Basal cell carcinoma with intense EpCAM positivity of all tumor cells.
Skin - Basal cell carcinoma showing strong EpCAM staining of tumor cells.
Skin – Basal cell carcinoma showing strong EpCAM staining of tumor cells.
Soft tissue - EPCAM negative leiomyosarcoma.
Soft tissue – EPCAM negative leiomyosarcoma.
Stomach - EPCAM negative gastrointestinal stromal tumor (GIST).
Stomach – EPCAM negative gastrointestinal stromal tumor (GIST).
Stomach - Gastric adenocarcinoma (diffuse type) with strong membranous EPCAM immunostaining of tumor cells.
Stomach – Gastric adenocarcinoma (diffuse type) with strong membranous EPCAM immunostaining of tumor cells.
Stomach - Gastric adenocarcinoma with strong EPCAM positivity of tumor cells.
Stomach – Gastric adenocarcinoma with strong EPCAM positivity of tumor cells.
Testis - Seminoma with moderate EPCAM immunostaining of tumor cells.
Testis – Seminoma with moderate EPCAM immunostaining of tumor cells.
Thorax - EPCAM negative epitheloid malignant mesothelioma.
Thorax – EPCAM negative epitheloid malignant mesothelioma.
Thorax - Epitheloid mesothelioma with moderate to strong EPCAM immunostaining of tumor cells.
Thorax – Epitheloid mesothelioma with moderate to strong EPCAM immunostaining of tumor cells.
Thyroid - EPCAM negative anaplastic carcinoma.
Thyroid – EPCAM negative anaplastic carcinoma.
Urinary bladder - EPCAM negative small cell carcinoma.
Urinary bladder – EPCAM negative small cell carcinoma.
Urinary bladder - Muscle-invasive urothelial carcinoma with strong membranous EPCAM positivity.
Urinary bladder – Muscle-invasive urothelial carcinoma with strong membranous EPCAM positivity.
Uterus, cervix - Squamous cell carcinoma with weak focal EPCAM positivity.
Uterus, cervix – Squamous cell carcinoma with weak focal EPCAM positivity.
Uterus, endometrium - Serous carcinoma with strong EPCAM immunostaining of tumor cells.
Uterus, endometrium – Serous carcinoma with strong EPCAM immunostaining of tumor cells.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors